Evidence map›Paper›PMID 31447677›Full record

SynthesisFrontiers in pharmacology2019

Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials.

Ling-Feng Zeng, Bi-Qi Pan, Gui-Hong Liang, Ming-Hui Luo, Ye Cao, Da Guo, Hong-Yun Chen, Jian-Ke Pan, He-Tao Huang, Qiang Liu and 13 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 1 country.

Ling-Feng ZengThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Bi-Qi PanDepartment of Traditional Chinese Medicine, Guangdong Women and Children Hospital, Guangzhou, China.
Gui-Hong LiangThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Ming-Hui LuoThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Ye CaoDepartment of Clinical Research/National Clinical Trials Institute, Sun Yat-sen University Cancer Center, Guangzhou, China.
Da GuoThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Hong-Yun ChenThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Jian-Ke PanThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
He-Tao HuangThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Qiang LiuWorld Federation of Chinese Medicine Societies, Beijing, China.
Zi-Tong GuanWorld Federation of Chinese Medicine Societies, Beijing, China.
Yan-Hong HanThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Di ZhaoThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jin-Long ZhaoThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Sen-Rong HouThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Ming WuThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jiong-Tong LinThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jia-Hui LiThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Wei-Xiong LiangThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Ai-Hua OuThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Qi WangThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Wei-Yi YangThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Jun LiuThe 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Guangzhou University of Chinese Medicine · CNGuangdong Academy of Medical Sciences · CNGuangdong Province Women and Children Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-osteoporosis medicationclinical trialsliterature reviewosteoporotic fracturerisk reductionroutine therapy

Identifiers

PMID31447677
PMCPMC6695469
OpenAlexW2962025676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.